Approximately 360 million people globally are living with a rare disease. Over half of these are children. Many of the diseases are life-threatening and only …
Vertex has announced that the EMA adopted a positive opinion for the label extension of Kaftrio®, in a combination regiment with ivacaftor, for the treatment …
Jaypreet Dhillon, Editorial Manager of Pharma Publications, Interviews Dr. Hermann Schulz, Chief Executive Officer INTERLAB Central Lab Services – Worldwide GmbH, Munich, Germany, on why paediatric trials are coming into focus now.
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
